Rapid Micro Biosystems director awarded stock, options
Rapid Micro Biosystems, Inc. director Richard S. Kollender reported equity awards under the company’s compensation program.
Rhea-AI Filing Summary
Rapid Micro Biosystems, Inc. director Richard S. Kollender reported equity awards under the company’s compensation program. He received 19,300 shares of Class A common stock as restricted stock units that were granted at no cash cost.
He was also granted stock options for 38,700 shares of Class A common stock at an exercise price of $2.07 per share, expiring on May 20, 2036. Both the RSUs and the options vest in full on the earlier of the first anniversary of the grant date or immediately before the next annual stockholders’ meeting, assuming continuous service. Following the RSU grant, he directly holds 130,318 shares of Class A common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 58,000 shares
Grant/Award
2 txns
Insider
Kollender Richard S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 38,700 | $0.00 | $0.00 |
| Grant/Award | Class A Common Stock | 19,300 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 38,700 contracts (Direct);
Class A Common Stock — 130,318 shares (Direct)
Footnotes (2)
- F1. Grant of restricted stock units ("RSUs") that vests in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date.
- F2. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the day immediately prior to the date of the next annual meeting of the stockholders of the Company provided that the Reporting Person remains in continuous service on such vesting date.
Key Figures
RSU grant: 19,300 shares
Option grant size: 38,700 options
Option exercise price: $2.07 per share
+2 more
5 metrics
RSU grant
19,300 shares
Restricted stock units of Class A common stock granted to director
Option grant size
38,700 options
Stock options for Class A common stock granted to director
Option exercise price
$2.07 per share
Exercise price of granted stock options
Option expiration
May 20, 2036
Expiration date of the granted stock options
Shares held after grant
130,318 shares
Director’s direct Class A common stock holdings following RSU grant
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Buy), exercise price, Grant Date, +1 more
5 terms
restricted stock units ("RSUs") financial
"Grant of restricted stock units ("RSUs") that vests in full on the earlier"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)","
exercise price financial
"conversion_or_exercise_price": "2.0700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Grant Date financial
"the first anniversary of the Grant Date, or (ii) the day immediately"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
annual meeting of the stockholders financial
"immediately prior to the date of the next annual meeting of the stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Rapid Micro Biosystems (RPID) report for Richard S. Kollender?
Rapid Micro Biosystems reported that director Richard S. Kollender received equity awards. The Form 4 shows a grant of restricted stock units and a separate grant of stock options, both as compensation rather than open-market purchases or sales.
What stock options did Richard Kollender receive from Rapid Micro Biosystems (RPID)?
He received stock options covering 38,700 shares of Class A common stock. The options have an exercise price of $2.07 per share and expire on May 20, 2036, and they vest in full on the same schedule as the restricted stock units.
When do Richard Kollender’s Rapid Micro Biosystems (RPID) RSUs and options vest?
Both the RSUs and the options vest in full on the earlier of the first anniversary of the grant date or the day immediately before the next annual stockholders’ meeting, provided Richard S. Kollender remains in continuous service with the company until that vesting date.
Are Richard Kollender’s Rapid Micro Biosystems (RPID) transactions open-market buys or sales?
The transactions are compensation-related grants, not open-market trades. The Form 4 lists them as awards of restricted stock units and stock options, both with a transaction code indicating grant or other acquisition rather than a market purchase or sale.
AI-generated analysis. How Rhea-AI works. Not financial advice.
